Step 1 topics → Hematology and Oncology → Sideroblastic Anemia

Sideroblastic Anemia

USMLE Step 1 trap: Misclassifies sideroblastic anemia as macrocytic rather than microcytic with a dimorphic smear. Sideroblastic anemia is microcytic (or normocytic) with a dimorphic smear showing both small hypochromic and normal RBCs; MCV may appear falsely normal due to averaging.

Sideroblastic anemia is a disorder of heme synthesis where iron accumulates in mitochondria surrounding the nucleus of developing red cells, producing the classic ring sideroblast seen on Prussian blue stain. USMLE Step 1 loves this topic because it creates a microcytic anemia that looks nothing like iron deficiency on the iron panel — and the most common wrong answer is applying the IDA pattern to both. In sideroblastic anemia, iron is abundant but stuck: ferritin is high, TIBC is low, serum iron is high — the polar opposite of IDA. The defect sits at ALA synthase, meaning iron arrives normally but can't get incorporated into protoporphyrin, so it just sits there, toxic and useless.

The exam tests sideroblastic anemia from three main angles: the mechanism (why ring sideroblasts form), the differential (acquired vs. congenital causes and what triggers each), and the labs (iron studies that look the opposite of IDA, plus the dimorphic smear). Passage-based questions may describe a patient on isoniazid or with alcohol use who develops anemia — your job is to recognize the cause and know the fix. Application questions might show you an iron panel and ask you to distinguish this from thalassemia or IDA.

The trickiest part is that students pattern-match 'microcytic anemia' to iron deficiency and apply the wrong iron panel. Sideroblastic anemia is iron-overloaded, not iron-depleted. The other major trap is the MCV: because you have a dimorphic population of small hypochromic cells AND normal cells, the automated MCV may read as normal — hiding the microcytic component entirely. Step 1 exploits both of these constantly.

From real student decks
65%have cards covering this topic
41%have mature cards

Common misconceptions

Common mistake
Wrong: Sideroblastic anemia is macrocytic because it involves a metabolic/enzymatic defect.
Right: Sideroblastic anemia is microcytic (or normocytic) with a dimorphic smear showing both small hypochromic and normal RBCs; MCV may appear falsely normal due to averaging.
Sideroblastic anemia is not macrocytic — it's microcytic or normocytic, and the distinction matters for differential diagnosis. The confusing part is the dimorphic smear: you have a mix of small hypochromic cells (from defective heme synthesis) and normal-sized cells, and automated analyzers average these two populations, often reporting a 'normal' MCV. Look at the smear itself and check the RDW — it will be elevated, reflecting that mixed population.
Common mistake
Wrong: Ring sideroblasts form because iron cannot be absorbed from the gut.
Right: Ring sideroblasts form because a defect in heme synthesis (e.g., ALA synthase deficiency) prevents iron incorporation into protoporphyrin, causing iron to accumulate in mitochondria ringing the nucleus.
Ring sideroblasts have nothing to do with impaired gut absorption — iron absorption is normal or even increased in sideroblastic anemia. The problem is intracellular: iron enters the developing red cell just fine, but a defect in ALA synthase (or another heme synthesis enzyme) means it can't be incorporated into the protoporphyrin ring. Iron then accumulates in the mitochondria, which encircle the nucleus, producing the ring pattern you see on Prussian blue stain.
Common mistake
Wrong: Sideroblastic anemia has low ferritin and high TIBC like IDA because both are microcytic.
Right: Sideroblastic anemia has high ferritin and low TIBC (iron-overloaded pattern) because iron is abundant but cannot be used for heme synthesis.
Do not apply the IDA iron panel to sideroblastic anemia just because both are microcytic — they are polar opposites. In IDA, the body is starved for iron: ferritin is low, TIBC is high (trying to grab more iron), and serum iron is low. In sideroblastic anemia, iron is abundant but stuck — so ferritin is high, TIBC is low (no need to carry more), and serum iron is high. The distinguishing question is: is there enough iron, or can it just not be used?
Common mistake
Gap: Unaware that pyridoxine (B6) treats B6-responsive sideroblastic anemia by restoring ALA synthase cofactor activity
Pyridoxine (B6) is the treatment for congenital X-linked sideroblastic anemia and isoniazid-induced sideroblastic anemia because B6 is a cofactor for ALA synthase, the rate-limiting enzyme in heme synthesis.
Pyridoxine (B6) works here because ALA synthase requires pyridoxal phosphate (the active form of B6) as a cofactor to catalyze the first and rate-limiting step of heme synthesis. When B6 is deficient — as in isoniazid use, which depletes B6, or in the congenital X-linked form where ALA synthase has reduced cofactor affinity — supplementing B6 can restore enough enzyme activity to improve anemia. This is a high-yield treatment connection: INH-induced sideroblastic anemia responds to B6, and the congenital X-linked form is 'B6-responsive.'
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the mechanism: a defect in heme synthesis (specifically ALA synthase) prevents iron from being incorporated into protoporphyrin, so iron accumulates in mitochondria surrounding the nucleus — this is what creates the ring sideroblast seen on Prussian blue stain.
  2. Distinguish acquired from congenital causes: congenital X-linked sideroblastic anemia involves an ALA synthase gene mutation; acquired causes include alcohol (most common), isoniazid, lead poisoning, and myelodysplastic syndrome — know which cause which and which respond to B6.
  3. Interpret the iron panel correctly: sideroblastic anemia shows high serum iron, high ferritin, low TIBC, and high transferrin saturation — the opposite of IDA — because the problem is iron utilization, not iron availability; also recognize the dimorphic smear and the fact that MCV may appear falsely normal.

Can you avoid these mistakes?

A patient on isoniazid therapy develops fatigue. CBC shows hemoglobin of 9.5 g/dL with a normal MCV, but the smear shows both small hypochromic and normal-appearing red cells. Serum iron is elevated and TIBC is low. What is the mechanism of anemia, and what is the treatment?
You are shown two iron panels: Patient A has low ferritin, high TIBC, low serum iron. Patient B has high ferritin, low TIBC, high serum iron. Both have microcytic anemia. Which pattern fits sideroblastic anemia, and what would you expect to see on bone marrow biopsy with Prussian blue stain?
A student says sideroblastic anemia is macrocytic because it's caused by an enzymatic defect, similar to B12/folate deficiency. How would you correct this reasoning, and why might the MCV appear normal even when the anemia is truly microcytic?
What is the difference in pathophysiology between iron deficiency anemia and sideroblastic anemia that explains why they have opposite iron panel results despite both causing microcytic anemia?

Related topics

Anemia Approach by MCV Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis

See how your Anki deck covers this topic.

Upload your deck for a free audit →